News | May 09, 2007

Cedara, Varian Pen Licensing Agreement

May 10, 2007 - Cedara Software, a Merge Healthcare company, announced it has concluded a licensing agreement with Varian Medical Systems, giving Varian exclusive global rights to distribute Cedara’s I-Response technology within the radiation and medical oncology market.
Cedara I-Response is a tool that analyzes how cancerous tumors are responding to treatment. I-Response supports multiple imaging modalities and features patented analysis of fDM (Functional Diffusion Mapping) MR images. It allows professionals to visualize and quantify changes in tumor tissue resulting from cellular and metabolic mechanisms, and then track the data over time. In this way, Cedara I-Response has the potential to precisely monitor the impact of anti-cancer drugs and radiation therapy early in the course of treatment, adding to the information that clinicians can reference when developing personalized treatment plans.
Cedara I-Response complements Varian’s Dynamic Adaptive Radiation Therapy (DART) program with its image analysis capabilities that assist oncologists in making treatment decisions for their patients. Cedara I-Response has received FDA 510k clearance and the company expects a commercial release in June 2007.

Related Content

Siris Medical Releases PlanMD Decision Support Software
Technology | Treatment Planning | October 24, 2018
Siris Medical Inc. announced the release of its new artificial intelligence (AI) treatment decision-support system for...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
HealthMyne QIDS Platform Adds Cancer Screening Module
Technology | Clinical Decision Support | August 21, 2018
HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer...
ACR LI-RADS Steering Committee Releases New Version of CT/MRI LI-RADS
News | Clinical Decision Support | August 13, 2018
August 13, 2018 — The American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) steering commit
Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
Technology | Clinical Decision Support | August 08, 2018
Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its...
Videos | Clinical Decision Support | August 03, 2018
Sheila Sferrella, president of Regents Health Resources and Bill Finerfrock, president of Capitol Associates, discuss
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
2019 Proposed Physician Fee Schedule Appropriate Use Criteria Summary
Feature | Clinical Decision Support | July 13, 2018 | Nathan Baugh
On July 12, the Centers for Medicare and Medicaid Services (CMS) released the proposed rule for the 2019 Physician Fe
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
Videos | Clinical Decision Support | March 22, 2018
Jonathan Teich, M.D., chief medical information officer for InterSystems, discusses the growth of clinical decision s